Literature DB >> 19279166

Evidence of a functional B-cell immunodeficiency in adults who experience serogroup C meningococcal disease.

Rachel A Foster1, Jennifer Carlring, Michael W McKendrick, Andrew Lees, Ray Borrow, Robert C Read, Andrew W Heath.   

Abstract

After adolescence, the incidence of meningococcal disease decreases with age as a result of the cumulative immunizing effect of repeated nasopharyngeal colonization. Nevertheless, some adults succumb to meningococcal disease, so we hypothesized that this is due to a subtle functional immunological defect. Peripheral blood lymphocytes derived from survivors of serogroup C meningococcal disease and from age- and sex-matched controls were incubated with a polyclonal B-cell activator containing anti-immunoglobulin D (alpha-delta-dex) employed to mimic antigen-specific stimuli encountered during immune responses to bacterial polysaccharides, with and without T-cell activation (using anti-CD3/anti-CD28). Subsequent proliferation and activation of T and B lymphocytes were measured. In patients, T-cell responses to polyclonal stimuli and the delivery of T-cell help to B cells were unimpaired. Levels of B-cell proliferation in response to alpha-delta-dex stimulation alone were low in all samples but were significantly lower in patients than in controls, and these differences were more pronounced with the addition of T-cell help. The data are consistent with the presence of a subtle immunodeficiency in adults who have exhibited susceptibility to meningococcal disease. This defect is manifested as an impaired B-cell response to T-cell-independent type 2 antigens analogous to bacterial capsular polysaccharide.

Entities:  

Mesh:

Year:  2009        PMID: 19279166      PMCID: PMC2681599          DOI: 10.1128/CVI.00485-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester.

Authors:  J Hasbold; A V Gett; J S Rush; E Deenick; D Avery; J Jun; P D Hodgkin
Journal:  Immunol Cell Biol       Date:  1999-12       Impact factor: 5.126

2.  Surviving a knockout blow.

Authors:  Helen Pearson
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

3.  Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

Authors:  Martin C J Maiden; James M Stuart
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

4.  Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.

Authors:  Yanwen Li; Qian Zhang; Megan Winterbotham; Eva Mowe; Andrew Gorringe; Christoph M Tang
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.

Authors:  Abdul Q Khan; Andrew Lees; Clifford M Snapper
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity.

Authors:  Jo Anne Welsch; Dan Granoff
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b.

Authors:  Jerry W Pickering; Thomas B Martins; M Carl Schroder; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.

Authors:  Gouri Lal; Paul Balmer; Helen Joseph; Maureen Dawson; Ray Borrow
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

9.  Characterization of humoral and cellular immune responses elicited by meningococcal carriage.

Authors:  K Robinson; K R Neal; C Howard; J Stockton; K Atkinson; E Scarth; J Moran; A Robins; I Todd; E Kaczmarski; S Gray; I Muscat; R Slack; D A A Ala'Aldeen
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  6 in total

1.  Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.

Authors:  Lorena Preciado-Llanes; James B Wing; Rachel A Foster; Jennifer Carlring; Andrew Lees; Robert C Read; Andrew W Heath
Journal:  Immunology       Date:  2014-09-20       Impact factor: 7.397

2.  Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.

Authors:  Rachel A Foster; Jennifer Carlring; Andrew Lees; Ray Borrow; Mary Ramsay; Ed Kacsmarski; Elizabeth Miller; Michael W McKendrick; Andrew W Heath; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

3.  Adult survivors of invasive pneumococcal disease exhibit defective B cell function.

Authors:  Tom C Darton; James B Wing; Andrew Lees; Andrew W Heath; Robert C Read
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.

Authors:  James B Wing; Lynne Smart; Ray Borrow; Jamie Findlow; Helen Findlow; Andrew Lees; Rachel A Foster; Jennifer Carlring; Robert C Read; Andrew W Heath
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

5.  CD154-CD40 interactions in the control of murine B cell hematopoiesis.

Authors:  Jennifer Carlring; Hala M Altaher; Susan Clark; Xi Chen; Sarah L Latimer; Tracey Jenner; Anne-Marie Buckle; Andrew W Heath
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

Review 6.  Importance of circulating antibodies in protection against meningococcal disease.

Authors:  Kim S Erlich; Blaise L Congeni
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.